# Sandisk Corp: financial statements, quarterly

SNDK · Nasdaq · CIK 2023554 · [Technology](/sectors/technology.md) · fiscal year ends Jun 28

Pages: [Overview](/companies/sndk.md) · [Financials](/companies/sndk/financials.md) · [Filings](/companies/sndk/filings.md) · [Insiders](/companies/sndk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sndk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-29) | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | period not labelled (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-10-03) | Q2 FY2026 (2026-01-02) | Q3 FY2026 (2026-04-03) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [1,665](/filings/0002023554-25-000016.md) | [1,705](/filings/0002023554-25-000027.md) | [1,760 d](/filings/0001628280-26-057406.md) | [1,883](/filings/0001628280-25-050698.md) | [1,876](/filings/0001628280-26-004407.md) | [1,695](/filings/0001628280-26-029401.md) | [1,901 d](/filings/0001628280-26-057406.md) | [2,308](/filings/0001628280-25-050698.md) | [3,025](/filings/0001628280-26-004407.md) | [5,950](/filings/0001628280-26-029401.md) | [8,965 d](/filings/0001628280-26-057406.md) |
| Cost of revenue | $m | not reported | [1,504](/filings/0002023554-25-000016.md) | [1,242](/filings/0002023554-25-000027.md) | [1,124 d](/filings/0001628280-26-057406.md) | [1,157](/filings/0001628280-25-050698.md) | [1,270](/filings/0001628280-26-004407.md) | [1,313](/filings/0001628280-26-029401.md) | [1,403 d](/filings/0001628280-26-057406.md) | [1,621](/filings/0001628280-25-050698.md) | [1,484](/filings/0001628280-26-004407.md) | [1,288](/filings/0001628280-26-029401.md) | [1,383 d](/filings/0001628280-26-057406.md) |
| Gross profit | $m | not reported | [161](/filings/0002023554-25-000016.md) | [463](/filings/0002023554-25-000027.md) | [636 d](/filings/0001628280-26-057406.md) | [726](/filings/0001628280-25-050698.md) | [606](/filings/0001628280-26-004407.md) | [382](/filings/0001628280-26-029401.md) | [498 d](/filings/0001628280-26-057406.md) | [687](/filings/0001628280-25-050698.md) | [1,541](/filings/0001628280-26-004407.md) | [4,662](/filings/0001628280-26-029401.md) | [7,582 d](/filings/0001628280-26-057406.md) |
| Research and development | $m | not reported | [246](/filings/0002023554-25-000016.md) | [277](/filings/0002023554-25-000027.md) | [298 d](/filings/0001628280-26-057406.md) | [283](/filings/0001628280-25-050698.md) | [279](/filings/0001628280-26-004407.md) | [285](/filings/0001628280-26-029401.md) | [285 d](/filings/0001628280-26-057406.md) | [316](/filings/0001628280-25-050698.md) | [327](/filings/0001628280-26-004407.md) | [337](/filings/0001628280-26-029401.md) | [348 d](/filings/0001628280-26-057406.md) |
| Selling, general and administrative | $m | not reported | [113](/filings/0002023554-25-000016.md) | [107](/filings/0002023554-25-000027.md) | [117 d](/filings/0001628280-26-057406.md) | [130](/filings/0001628280-25-050698.md) | [142](/filings/0001628280-26-004407.md) | [139](/filings/0001628280-26-029401.md) | [162 d](/filings/0001628280-26-057406.md) | [179](/filings/0001628280-25-050698.md) | [139](/filings/0001628280-26-004407.md) | [161](/filings/0001628280-26-029401.md) | [197 d](/filings/0001628280-26-057406.md) |
| Operating income | $m | not reported | [(245)](/filings/0002023554-25-000016.md) | [65.0](/filings/0002023554-25-000027.md) | [199 d](/filings/0001628280-26-057406.md) | [291](/filings/0001628280-25-050698.md) | [195](/filings/0001628280-26-004407.md) | [(1,881)](/filings/0001628280-26-029401.md) | [18.0 d](/filings/0001628280-26-057406.md) | [176](/filings/0001628280-25-050698.md) | [1,065](/filings/0001628280-26-004407.md) | [4,111](/filings/0001628280-26-029401.md) | [7,037 d](/filings/0001628280-26-057406.md) |
| Interest expense | $m | not reported | [11.0](/filings/0002023554-25-000016.md) | [9.0](/filings/0002023554-25-000027.md) | [9.0 d](/filings/0001628280-26-057406.md) | [2.0](/filings/0001628280-25-050698.md) | [4.0](/filings/0001628280-26-004407.md) | [16.0](/filings/0001628280-26-029401.md) | [41.0 d](/filings/0001628280-26-057406.md) | [40.0](/filings/0001628280-25-050698.md) | [25.0](/filings/0001628280-26-004407.md) | [6.0](/filings/0001628280-26-029401.md) | [2.0 d](/filings/0001628280-26-057406.md) |
| Income tax | $m | not reported | [41.0](/filings/0002023554-25-000016.md) | [27.0](/filings/0002023554-25-000027.md) | [169](/filings/0002023554-25-000034.md) | [56.0](/filings/0001628280-25-050698.md) | [69.0](/filings/0001628280-26-004407.md) | [32.0](/filings/0001628280-26-029401.md) | [162](/filings/0002023554-25-000034.md) | [12.0](/filings/0001628280-25-050698.md) | [134](/filings/0001628280-26-004407.md) | [492](/filings/0001628280-26-029401.md) | [946 d](/filings/0001628280-26-057406.md) |
| Net income | $m | [(518)](/filings/0002023554-25-000027.md) | [(301)](/filings/0002023554-25-000027.md) | [27.0](/filings/0002023554-25-000027.md) | [120 d](/filings/0001628280-26-057406.md) | [211](/filings/0001628280-26-029401.md) | [104](/filings/0001628280-26-029401.md) | [(1,933)](/filings/0001628280-26-029401.md) | [(23.0) d](/filings/0001628280-26-057406.md) | [112](/filings/0001628280-26-029401.md) | [803](/filings/0001628280-26-029401.md) | [3,615](/filings/0001628280-26-029401.md) | [6,903 d](/filings/0001628280-26-057406.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.19](/filings/0002023554-25-000027.md) | not reported | [1.46](/filings/0001628280-25-050698.md) | [0.72](/filings/0001628280-26-004407.md) | [(13.33)](/filings/0001628280-26-029401.md) | not reported | [0.75](/filings/0001628280-25-050698.md) | [5.15](/filings/0001628280-26-004407.md) | [23.03](/filings/0001628280-26-029401.md) | not reported |
| Basic EPS | $ per share | not reported | not reported | [0.19](/filings/0002023554-25-000027.md) | not reported | [1.46](/filings/0001628280-25-050698.md) | [0.72](/filings/0001628280-26-004407.md) | [(13.33)](/filings/0001628280-26-029401.md) | not reported | [0.77](/filings/0001628280-25-050698.md) | [5.46](/filings/0001628280-26-004407.md) | [24.43](/filings/0001628280-26-029401.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-29) | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | period not labelled (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | FY2025 (2025-06-27) | Q1 FY2026 (2025-10-03) | Q2 FY2026 (2026-01-02) | Q3 FY2026 (2026-04-03) | FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | [0.3](/filings/0002023554-25-000034.md) | not reported | [0.8](/filings/0002023554-25-000016.md) | [1.5](/filings/0002023554-25-000027.md) | [1.5](/filings/0001628280-26-057406.md) | [1.4](/filings/0001628280-25-050698.md) | [1.5](/filings/0001628280-26-004407.md) | [3.7](/filings/0001628280-26-029401.md) | [4.8](/filings/0001628280-26-057406.md) |
| Current assets | $bn | not reported | not reported | not reported | [3.5](/filings/0002023554-25-000034.md) | not reported | [4.5](/filings/0002023554-25-000016.md) | [5.1](/filings/0002023554-25-000027.md) | [5.1](/filings/0001628280-26-057406.md) | [5.0](/filings/0001628280-25-050698.md) | [5.2](/filings/0001628280-26-004407.md) | [9.2](/filings/0001628280-26-029401.md) | [12.8](/filings/0001628280-26-057406.md) |
| Total assets | $bn | not reported | not reported | not reported | [13.5](/filings/0002023554-25-000034.md) | not reported | [14.2](/filings/0002023554-25-000016.md) | [13.0](/filings/0002023554-25-000027.md) | [13.0](/filings/0001628280-26-057406.md) | [12.7](/filings/0001628280-25-050698.md) | [13.0](/filings/0001628280-26-004407.md) | [17.1](/filings/0001628280-26-029401.md) | [22.5](/filings/0001628280-26-057406.md) |
| Current liabilities | $bn | not reported | not reported | not reported | [2.1](/filings/0002023554-25-000034.md) | not reported | [1.9](/filings/0002023554-25-000016.md) | [1.4](/filings/0002023554-25-000027.md) | [1.4](/filings/0001628280-26-057406.md) | [1.5](/filings/0001628280-25-050698.md) | [1.7](/filings/0001628280-26-004407.md) | [1.9](/filings/0001628280-26-029401.md) | [5.6](/filings/0001628280-26-057406.md) |
| Total liabilities | $bn | not reported | not reported | not reported | [2.4](/filings/0002023554-25-000034.md) | not reported | [2.2](/filings/0002023554-25-000016.md) | [3.8](/filings/0002023554-25-000027.md) | [3.8](/filings/0001628280-26-057406.md) | [3.4](/filings/0001628280-25-050698.md) | [2.8](/filings/0001628280-26-004407.md) | [3.3](/filings/0001628280-26-029401.md) | [6.8](/filings/0001628280-26-057406.md) |
| Long-term debt | $bn | not reported | not reported | not reported | [0.0](/filings/0002023554-25-000034.md) | not reported | not reported | [1.9](/filings/0002023554-25-000027.md) | [1.8](/filings/0001628280-26-057406.md) | [1.3](/filings/0001628280-25-050698.md) | [0.6](/filings/0001628280-26-004407.md) | [0.0](/filings/0001628280-26-029401.md) | [0.0](/filings/0001628280-26-057406.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | [0.0](/filings/0002023554-25-000034.md) | not reported | not reported | [0.0](/filings/0002023554-25-000027.md) | [0.0](/filings/0001628280-26-057406.md) | [0.0](/filings/0001628280-25-050698.md) | [0.0](/filings/0001628280-26-004407.md) | [0.0](/filings/0001628280-26-029401.md) | [0.0](/filings/0001628280-26-057406.md) |
| Shareholders' equity | $bn | [10.9](/filings/0002023554-25-000027.md) | [10.9](/filings/0002023554-25-000027.md) | [10.9](/filings/0002023554-25-000027.md) | [11.1](/filings/0001628280-26-057406.md) | [12.1](/filings/0001628280-26-029401.md) | [12.0](/filings/0001628280-26-029401.md) | [9.2](/filings/0001628280-26-029401.md) | [9.2](/filings/0001628280-26-057406.md) | [9.4](/filings/0001628280-26-029401.md) | [10.2](/filings/0001628280-26-029401.md) | [13.8](/filings/0001628280-26-029401.md) | [15.7](/filings/0001628280-26-057406.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-29) | period not labelled (2024-06-28) | period not labelled (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-10-03) | Q2 FY2026 (2026-01-02) | Q3 FY2026 (2026-04-03) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.0) d](/filings/0002023554-25-000027.md) | [(130) d](/filings/0001628280-26-057406.md) | [(131)](/filings/0001628280-25-050698.md) | [95.0 d](/filings/0001628280-26-004407.md) | [26.0 d](/filings/0001628280-26-029401.md) | [94.0 d](/filings/0001628280-26-057406.md) | [488](/filings/0001628280-25-050698.md) | [1,019 d](/filings/0001628280-26-004407.md) | [3,038 d](/filings/0001628280-26-029401.md) | [7,126 d](/filings/0001628280-26-057406.md) |
| Capital expenditure | $m | [29.0 d](/filings/0002023554-25-000027.md) | [38.0 d](/filings/0001628280-26-057406.md) | [67.0](/filings/0001628280-25-050698.md) | [48.0 d](/filings/0001628280-26-004407.md) | [44.0 d](/filings/0001628280-26-029401.md) | [45.0 d](/filings/0001628280-26-057406.md) | [50.0](/filings/0001628280-25-050698.md) | [39.0 d](/filings/0001628280-26-004407.md) | [45.0 d](/filings/0001628280-26-029401.md) | [43.0 d](/filings/0001628280-26-057406.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-29) | period not labelled (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q1 FY2026 (2025-10-03) | Q2 FY2026 (2026-01-02) | Q3 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [145](/filings/0002023554-25-000027.md) | [145](/filings/0001628280-25-050698.md) | [145](/filings/0001628280-26-004407.md) | [145](/filings/0001628280-26-029401.md) | [149](/filings/0001628280-25-050698.md) | [156](/filings/0001628280-26-004407.md) | [157](/filings/0001628280-26-029401.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 146,419,001 at 2026-08-07, from the cover of the [10-K filed 2026-08-17](/filings/0001628280-26-057406.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.